238 related articles for article (PubMed ID: 29205277)
1. Clinical and genetic factors are associated with pain and hospitalisation rates in sickle cell anaemia in Cameroon.
Wonkam A; Mnika K; Ngo Bitoungui VJ; Chetcha Chemegni B; Chimusa ER; Dandara C; Kengne AP
Br J Haematol; 2018 Jan; 180(1):134-146. PubMed ID: 29205277
[TBL] [Abstract][Full Text] [Related]
2. Association of variants at BCL11A and HBS1L-MYB with hemoglobin F and hospitalization rates among sickle cell patients in Cameroon.
Wonkam A; Ngo Bitoungui VJ; Vorster AA; Ramesar R; Cooper RS; Tayo B; Lettre G; Ngogang J
PLoS One; 2014; 9(3):e92506. PubMed ID: 24667352
[TBL] [Abstract][Full Text] [Related]
3. Clinical and genetic predictors of renal dysfunctions in sickle cell anaemia in Cameroon.
Geard A; Pule GD; Chetcha Chemegni B; Ngo Bitoungui VJ; Kengne AP; Chimusa ER; Wonkam A
Br J Haematol; 2017 Aug; 178(4):629-639. PubMed ID: 28466968
[TBL] [Abstract][Full Text] [Related]
4. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.
Lettre G; Sankaran VG; Bezerra MA; Araújo AS; Uda M; Sanna S; Cao A; Schlessinger D; Costa FF; Hirschhorn JN; Orkin SH
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11869-74. PubMed ID: 18667698
[TBL] [Abstract][Full Text] [Related]
5. Association between BCL11A, HSB1L-MYB, and XmnI γG-158 (C/T) gene polymorphism and hemoglobin F level in Egyptian sickle cell disease patients.
El-Ghamrawy M; Yassa ME; Tousson AMS; El-Hady MA; Mikhaeil E; Mohamed NB; Khorshied MM
Ann Hematol; 2020 Oct; 99(10):2279-2288. PubMed ID: 32772141
[TBL] [Abstract][Full Text] [Related]
6. Functional polymorphisms of BCL11A and HBS1L-MYB genes affect both fetal hemoglobin level and clinical outcomes in a cohort of children with sickle cell anemia.
Sales RR; Belisário AR; Faria G; Mendes F; Luizon MR; Viana MB
Ann Hematol; 2020 Jul; 99(7):1453-1463. PubMed ID: 32447424
[TBL] [Abstract][Full Text] [Related]
7. Combined and differential effects of alpha-thalassemia and HbF-quantitative trait loci in Senegalese hydroxyurea-free children with sickle cell anemia.
Gueye Tall F; Martin C; Ndour EHM; Renoux C; Ly ID; Connes P; Gueye PM; Diallo RN; Diagne I; Diop PA; Cissé A; Lopez Sall P; Joly P
Pediatr Blood Cancer; 2019 Oct; 66(10):e27934. PubMed ID: 31322815
[TBL] [Abstract][Full Text] [Related]
8. SAR1a promoter polymorphisms are not associated with fetal hemoglobin in patients with sickle cell disease from Cameroon.
Pule GD; Bitoungui VJN; Chemegni BC; Kengne AP; Wonkam A
BMC Res Notes; 2017 May; 10(1):183. PubMed ID: 28499394
[TBL] [Abstract][Full Text] [Related]
9. Genetic Modifiers of Sickle Cell Disease: A Genotype-Phenotype Relationship Study in a Cohort of 82 Children on Mayotte Island.
Muszlak M; Pissard S; Badens C; Chamouine A; Maillard O; Thuret I
Hemoglobin; 2015; 39(3):156-61. PubMed ID: 25806420
[TBL] [Abstract][Full Text] [Related]
10. The genetic dissection of fetal haemoglobin persistence in sickle cell disease in Nigeria.
Ojewunmi OO; Adeyemo TA; Oyetunji AI; Inyang B; Akinrindoye A; Mkumbe BS; Gardner K; Rooks H; Brewin J; Patel H; Lee SH; Chung R; Rashkin S; Kang G; Chianumba R; Sangeda R; Mwita L; Isa H; Agumadu UN; Ekong R; Faruk JA; Jamoh BY; Adebiyi NM; Umar IA; Hassan A; Grace C; Goel A; Inusa BPD; Falchi M; Nkya S; Makani J; Ahmad HR; Nnodu O; Strouboulis J; Menzel S
Hum Mol Genet; 2024 May; 33(10):919-929. PubMed ID: 38339995
[TBL] [Abstract][Full Text] [Related]
11. Genotyping the
Taleb Brahim A; Taleb M; Soumaré H; Ghaber SM; Mohamed A; Ould Mohamed Salem Boukhary A
Front Biosci (Schol Ed); 2024 Jun; 16(2):11. PubMed ID: 38939975
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants at HbF-modifier loci moderate anemia and leukocytosis in sickle cell disease in Tanzania.
Mtatiro SN; Makani J; Mmbando B; Thein SL; Menzel S; Cox SE
Am J Hematol; 2015 Jan; 90(1):E1-4. PubMed ID: 25263325
[TBL] [Abstract][Full Text] [Related]
13. The co-inheritance of alpha-thalassemia and sickle cell anemia is associated with better hematological indices and lower consultations rate in Cameroonian patients and could improve their survival.
Rumaney MB; Ngo Bitoungui VJ; Vorster AA; Ramesar R; Kengne AP; Ngogang J; Wonkam A
PLoS One; 2014; 9(6):e100516. PubMed ID: 24978191
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism at BCL11A compared to HBS1L-MYB loci explains less of the variance in HbF in patients with sickle cell disease in Cameroon.
Bitoungui VJ; Ngogang J; Wonkam A
Blood Cells Mol Dis; 2015 Mar; 54(3):268-9. PubMed ID: 25488618
[No Abstract] [Full Text] [Related]
15. Protein Z polymorphisms associated with vaso-occlusive crisis in young sickle cell disease patients.
Mahdi N; Abu-Hijleh TM; Abu-Hijleh FM; Sater MS; Al-Ola K; Almawi WY
Ann Hematol; 2012 Aug; 91(8):1215-20. PubMed ID: 22576309
[TBL] [Abstract][Full Text] [Related]
16. Whole blood transcriptomic analysis reveals PLSCR4 as a potential marker for vaso-occlusive crises in sickle cell disease.
Abdulwahab H; Aljishi M; Sultan A; Al-Kafaji G; Sridharan K; Bakhiet M; Taha S
Sci Rep; 2021 Nov; 11(1):22199. PubMed ID: 34772994
[TBL] [Abstract][Full Text] [Related]
17. Clinical and genetic factors are associated with kidney complications in African children with sickle cell anaemia.
Adebayo OC; Betukumesu DK; Nkoy AB; Adesoji OM; Ekulu PM; Van den Heuvel LP; Levtchenko EN; Labarque V
Br J Haematol; 2022 Jan; 196(1):204-214. PubMed ID: 34545573
[TBL] [Abstract][Full Text] [Related]
18. Studies of novel variants associated with Hb F in Sardinians and Tanzanians in sickle cell disease patients from Cameroon.
Pule GD; Ngo Bitoungui VJ; Chetcha Chemegni B; Kengne AP; Wonkam A
Hemoglobin; 2016 Nov; 40(6):377-380. PubMed ID: 27829299
[TBL] [Abstract][Full Text] [Related]
19. A survey of genetic fetal-haemoglobin modifiers in Nigerian patients with sickle cell anaemia.
Adeyemo TA; Ojewunmi OO; Oyetunji IA; Rooks H; Rees DC; Akinsulie AO; Akanmu AS; Thein SL; Menzel S
PLoS One; 2018; 13(6):e0197927. PubMed ID: 29879141
[TBL] [Abstract][Full Text] [Related]
20. Genetic association of fetal-hemoglobin levels in individuals with sickle cell disease in Tanzania maps to conserved regulatory elements within the MYB core enhancer.
Mtatiro SN; Mgaya J; Singh T; Mariki H; Rooks H; Soka D; Mmbando B; Thein SL; Barrett JC; Makani J; Cox SE; Menzel S
BMC Med Genet; 2015 Feb; 16():4. PubMed ID: 25928412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
